AR and metabolic syndrome: Supporting the notion of the liver as a major target organ, male mice with liver-specific inactivation of the AR [hepatic androgen receptor knockout (H-ARKO)] develop diet-induced obesity, insulin resistance, hepatic steatosis, and dyslipidemia (44).